BGC > Product Search > 16-Dehydro Pregnenolone Acetate | 979-02-2

Content	98.5-99.0%
Main impurities	1.5%max
Dry weight loss	0.5%max
Transparency	1/100 ethyl alcohol solution clarifying
Property	White or white crystal powder
Package	5kg/tin, both tin outside carton
Carton size	L52cm*H39cm*W29cm
Carton GW	13.5kg
Loadweight per 20GP	7mts
Usage	Used for making intermediates of residual hormonic medicine which can be made into such hormonic medicine as cortisong, floucinoline acetonide, progesterone and testosterone, ets.

Content	98.5-99.0%
Main impurities	1.5%max
Dry weight loss	0.5%max
Transparency	1/100 ethyl alcohol solution clarifying
Property	White or white crystal powder
Package	5kg/tin, both tin outside carton
Carton size	L52cm*H39cm*W29cm
Carton GW	13.5kg
Loadweight per 20GP	7mts
Usage	Used for making intermediates of residual hormonic medicine which can be made into such hormonic medicine as cortisong, floucinoline acetonide, progesterone and testosterone, ets.

Content	98.5-99.0%
Main impurities	1.5%max
Dry weight loss	0.5%max
Transparency	1/100 ethyl alcohol solution clarifying
Property	White or white crystal powder
Package	5kg/tin, both tin outside carton
Carton size	L52cm*H39cm*W29cm
Carton GW	13.5kg
Loadweight per 20GP	7mts
Usage	Used for making intermediates of residual hormonic medicine which can be made into such hormonic medicine as cortisong, floucinoline acetonide, progesterone and testosterone, ets.

Content	98.5-99.0%
Main impurities	1.5%max
Dry weight loss	0.5%max
Transparency	1/100 ethyl alcohol solution clarifying
Property	White or white crystal powder
Package	5kg/tin, both tin outside carton
Carton size	L52cm*H39cm*W29cm
Carton GW	13.5kg
Loadweight per 20GP	7mts
Usage	Used for making intermediates of residual hormonic medicine which can be made into such hormonic medicine as cortisong, floucinoline acetonide, progesterone and testosterone, ets.

Molecular Formula: C23H32O3
Molecular Weight: 356.5
Hazard Symbols: Xi
WGKGermany: 2

Specification	Min99.0%
Documentation	TP

Specification	Min99.0%
Documentation	TP

Specification	Min99.0%
Documentation	TP

Specification	Min99.0%
Documentation	TP

Specification	Min99.0%
Documentation	TP

Specification	Min99.0%
Documentation	TP

Description :
16-Dehydropregnenolone acetate is an impurity of Abiraterone, which is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga.

• Molecular Weight :356.51
• Boiling Point :464.4±45.0 °C(Predicted)
• Melting Point :167-170°C
• Purity :> 95%

Molecular Formula :
C23H32O3
Canonical SMILES :
CC(=O)C1=CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C)C)C
InChI :
InChI=1S/C23H32O3/c1-14(24)19-7-8-20-18-6-5-16-13-17(26-15(2)25)9-11-22(16,3)21(18)10-12-23(19,20)4/h5,7,17-18,20-21H,6,8-13H2,1-4H3/t17-,18-,20-,21-,22-,23+/m0/s1
InChIKey :
MZWRIOUCMXPLKV-RFOVXIPZSA-N
Appearance :
White to Off-white Solid
Storage : Store at 2 - 8 °C
Synonyms :
Dehydropregnenolone acetate; 16,17-Didehydropregnenolone acetate

More details are to be found here

Assay : 99%

Assay : 99%

Assay : 99%

Assay : 99%

Assay : 99%

Assay : 99%

Assay : 99%